176 related articles for article (PubMed ID: 36200071)
1. Structural insights into the binding of zoledronic acid with RANKL
Wang R; Zhang W; Ma H; Zou D; Zhang Z; Wang S
Front Mol Biosci; 2022; 9():992473. PubMed ID: 36200071
[TBL] [Abstract][Full Text] [Related]
2. Zoledronate treatment duration is linked to bisphosphonate-related osteonecrosis of the jaw prevalence in rice rats with generalized periodontitis.
Messer JG; Jiron JM; Mendieta Calle JL; Castillo EJ; Israel R; Phillips EG; Yarrow JF; Van Poznak C; Kesavalu L; Kimmel DB; Aguirre JI
Oral Dis; 2019 May; 25(4):1116-1135. PubMed ID: 30712276
[TBL] [Abstract][Full Text] [Related]
3. Impaired bone resorption and woven bone formation are associated with development of osteonecrosis of the jaw-like lesions by bisphosphonate and anti-receptor activator of NF-κB ligand antibody in mice.
Williams DW; Lee C; Kim T; Yagita H; Wu H; Park S; Yang P; Liu H; Shi S; Shin KH; Kang MK; Park NH; Kim RH
Am J Pathol; 2014 Nov; 184(11):3084-93. PubMed ID: 25173134
[TBL] [Abstract][Full Text] [Related]
4. Zoledronic Acid Accelerates ER Stress-Mediated Inflammation by Increasing PDE4B Expression in Bisphosphonate-Related Osteonecrosis of the Jaw.
Xz Q; Zq S; L L; Hs O
Appl Biochem Biotechnol; 2024 Mar; ():. PubMed ID: 38523176
[TBL] [Abstract][Full Text] [Related]
5. Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in mice.
Kobayashi Y; Hiraga T; Ueda A; Wang L; Matsumoto-Nakano M; Hata K; Yatani H; Yoneda T
J Bone Miner Metab; 2010 Mar; 28(2):165-75. PubMed ID: 19882100
[TBL] [Abstract][Full Text] [Related]
6. Zoledronic Acid Deteriorates Soft and Hard Tissue Healing of Murine Tooth Extraction Sockets in a Dose-Dependent Manner.
Kozutsumi R; Kuroshima S; Kaneko H; Sasaki M; Ishisaki A; Sawase T
Calcif Tissue Int; 2022 Jan; 110(1):104-116. PubMed ID: 34363509
[TBL] [Abstract][Full Text] [Related]
7. Establishment of an Animal Model of Bisphosphonate-Related Osteonecrosis of the Jaws in Spontaneously Diabetic Torii Rats.
Takaoka K; Yamamura M; Nishioka T; Abe T; Tamaoka J; Segawa E; Shinohara M; Ueda H; Kishimoto H; Urade M
PLoS One; 2015; 10(12):e0144355. PubMed ID: 26659123
[TBL] [Abstract][Full Text] [Related]
8. Small Extracellular Vesicles Derived from Adipose Tissue Prevent Bisphosphonate-Related Osteonecrosis of the Jaw by Promoting Angiogenesis.
Huang J; Wang L; Tian W
Int J Nanomedicine; 2021; 16():3161-3172. PubMed ID: 33994785
[TBL] [Abstract][Full Text] [Related]
9. Administration of zoledronic acid alleviates osteoporosis in HIV patients by suppressing osteoclastogenesis via regulating RANKL expression.
Lin W; Li XF; Ren DC; Song M; Duan L; Liu JZ; Zhan ZR
Mol Med; 2021 Feb; 27(1):19. PubMed ID: 33637048
[TBL] [Abstract][Full Text] [Related]
10. Aminobisphosphonate-treated ewes as a model of osteonecrosis of the jaw and of dental implant failure.
Davison MR; Lyardet L; Preliasco M; Yaful G; Torres P; Bonanno MS; Pellegrini GG; Zeni SN
J Periodontol; 2020 May; 91(5):628-637. PubMed ID: 31755105
[TBL] [Abstract][Full Text] [Related]
11. Effects of Anti-Receptor Activator of Nuclear Factor Kappa B Ligand Antibody and Zoledronic Acid on Periapical Lesion Development in Mice.
Ikeda M; Karakawa A; Takizawa H; Azetsu Y; Sakai N; Chatani M; Suzuki N; Takami M
J Endod; 2022 May; 48(5):632-640. PubMed ID: 35181456
[TBL] [Abstract][Full Text] [Related]
12. Zoledronic acid inhibits osteoclastogenesis and bone resorptive function by suppressing RANKL‑mediated NF‑κB and JNK and their downstream signalling pathways.
Huang XL; Liu C; Shi XM; Cheng YT; Zhou Q; Li JP; Liao J
Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34935053
[TBL] [Abstract][Full Text] [Related]
13. The ZOTECT study: Effect of zoledronic acid on bone metabolism in patients with bone metastases from prostate or breast cancer.
Hadji P; Ziller M; Maurer T; Autenrieth M; Muth M; Ruebel A; May C; Birkholz K; Diebel E; Gleissner J; Rothe P; Gschwend JE
J Bone Oncol; 2012 Dec; 1(3):88-94. PubMed ID: 26909262
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers for Bisphosphonate-Related Osteonecrosis of the Jaw.
Kim JW; Cha IH; Kim SJ; Kim MR
Clin Implant Dent Relat Res; 2016 Apr; 18(2):281-91. PubMed ID: 25726720
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial photodynamic therapy improves the alveolar repair process and prevents the occurrence of osteonecrosis of the jaws after tooth extraction in senile rats treated with zoledronate.
Ervolino E; Statkievicz C; Toro LF; de Mello-Neto JM; Cavazana TP; Issa JPM; Dornelles RCM; de Almeida JM; Nagata MJH; Okamoto R; Casatti CA; Garcia VG; Theodoro LH
Bone; 2019 Mar; 120():101-113. PubMed ID: 30339908
[TBL] [Abstract][Full Text] [Related]
16. Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: role in the interactions with receptor activator of nuclear factor kappaB ligand (RANKL) and RANK.
Théoleyre S; Kwan Tat S; Vusio P; Blanchard F; Gallagher J; Ricard-Blum S; Fortun Y; Padrines M; Rédini F; Heymann D
Biochem Biophys Res Commun; 2006 Aug; 347(2):460-7. PubMed ID: 16828054
[TBL] [Abstract][Full Text] [Related]
17. Zoledronic acid increases the prevalence of medication-related osteonecrosis of the jaw in a dose dependent manner in rice rats (Oryzomys palustris) with localized periodontitis.
Messer JG; Mendieta Calle JL; Jiron JM; Castillo EJ; Van Poznak C; Bhattacharyya N; Kimmel DB; Aguirre JI
Bone; 2018 Mar; 108():79-88. PubMed ID: 29289789
[TBL] [Abstract][Full Text] [Related]
18. Preventing or controlling periodontitis reduces the occurrence of osteonecrosis of the jaw (ONJ) in rice rats (Oryzomys palustris).
Castillo EJ; Messer JG; Abraham AM; Jiron JM; Alekseyenko AV; Israel R; Thomas S; Gonzalez-Perez GM; Croft S; Gohel A; Bhattacharyya I; Yarrow JF; Novince CM; Kimmel DB; Aguirre JI
Bone; 2021 Apr; 145():115866. PubMed ID: 33515777
[TBL] [Abstract][Full Text] [Related]
19. PDGF-BB exhibited therapeutic effects on rat model of bisphosphonate-related osteonecrosis of the jaw by enhancing angiogenesis and osteogenesis.
Gao SY; Lin RB; Huang SH; Liang YJ; Li X; Zhang SE; Ouyang DQ; Li K; Zheng GS; Liao GQ
Bone; 2021 Mar; 144():115117. PubMed ID: 31676407
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of RANKL and OPG, and the RANKL/OPG ratio in bisphosphonate-related osteonecrosis of the jaw: Are they useful biomarkers for the advanced stages of osteonecrosis?
Bagan L; Jiménez Y; Leopoldo M; Rubert A; Bagan J
Med Oral Patol Oral Cir Bucal; 2017 Sep; 22(5):e542-e547. PubMed ID: 28809381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
